Texas Heart Institute Home
Continuing Medical Education
 
CME Home
 
 13th Texas Update in Cardiovascular Advancements  

13th
Texas Update in
Cardiovascular Advancements

Presented by

Texas Heart Institute


Saturday
December 7,  2013

Texas Heart Institute
Houston, Texas


Register online now!

Program Overview
   
Heart and vascular disease is the #1 killer throughout the world for men, women and children. A death from heart or vascular disease occurs every 33 seconds, with 2,600 deaths occurring each day, and more than one million deaths occurring each year. There are 43 million women in the United States at this moment living with heart or vascular disease. In contrast, there are 5 million women living with cancer in the US presently. A woman is 5 times more likely to die of heart disease than of breast cancer.  More women die of heart and vascular disease than of all cancers combined. A young person dies on the playing fields in the US every 2 to 3 weeks. 

Over the past decade, physicians and scientists have worked diligently to find ways to combat the various physiological and behavioral risk factors and the genetic alterations associated with cardiovascular disease. Our one-day symposium will feature lectures and discussions by distinguished faculty who will provide current information on the status and future directions of cardiovascular medicine and surgery. The faculty will highlight recent progress in the diagnosis and treatment of cardiovascular disease, as well as new therapeutic modalities.

Target Audience
The audience for this continuing medical education activity includes cardiologists, cardiovascular surgeons, internists, clinical researchers, nurses, technicians, and all interested in cardiovascular diseases.

Learning Objectives
At the conclusion of this symposium, participants should be able to -

  • Discuss recent scientific advances in lipid management and the use of statins for acute and chronic coronary artery disease.
  • Review newer pharmacologic platforms for ST elevation MI.
  • Describe advances in the medical and interventional treatment of unstable angina and non-Q wave MI.
  • Determine the appropriate use of CT and MRI/MRA for diagnosing cardiovascular disease.
  • Discuss latest findings related to pathogenesis of hypertrophic cardiomyopathy and its treatment.
  • Cite new surgical options with robotic surgery, and its role in modern-day surgical practice.
  • Assess the latest surgical devices available to treat acute, decompensated heart failure patients.
  • Recognize the potential therapeutic options with stem cell therapy for cardiovascular disease including congestive heart failure.
  • Highlight new advances in electrophysiology, including biventricular pacing, defibrillation, and ablation.
  • Discuss how genetic discovery is being used to identify patients at risk for premature MIs. 
  • Identify specific PCI characteristics that are associated with a higher risk of very late complications, including stent thrombosis.
  • Discuss the use of stem cell therapy in the regeneration of damaged heart tissue.

Faculty

Blase A. Carabello, MD
Benjamin Y. Cheong, MD
William E. Cohn, MD
Denton A. Cooley, MD
Alain G. Cribier, MD
R. David Fish, MD
O.H. Frazier, MD
Peter H. Jones, MD
Hari R. Mallidi, MD
A.J. Marian, MD
Ali Massumi, MD
Deborah E. Meyers, MD
Dianna M. Milewicz, MD, PhD
Emerson C. Perin, MD, PhD
James T. Willerson, MD - Program Director
James M. Wilson, MD

Program Schedule

Saturday December 7, 2013  

SESSION I

7:00 a.m.     Continental Breakfast

7:30 a.m.     Welcome and Introductions
                    James T. Willerson, MD

7:45 a.m.     Lipid Advances: New Guidelines,
                    Risk Assessment and Future Treatments
                    Peter H. Jones, MD

8:15 a.m.     Advances in the Medical Treatment of
                    Unstable Angina and Non-Q Wave MI
                    James T. Willerson, MD

8:45 a.m.     Advances in Interventional Cardiology
                    R. David Fish, MD
            
9:15 a.m.     Advances in the Treatment of ST Elevation MI
                    James M. Wilson, MD

9:45 a.m.     Break


SESSION II

10:00 a.m.  Advances in CT and MRI/MRA to
                    Recognize Cardiovascular Disease
                    Benjamin Cheong, MD

10:30 a.m.   Advances in the Treatment of
                    Valvular Heart Disease
                    Blase Carabello, MD

11:00 a.m.  Latest in Electrophysiology Procedures
                    Ali Massumi, MD

11:30 a.m.   Stem Cell Therapy in the Treatment of CHF
                    and Cardiovascular Disease
                    Emerson C. Perin, MD, PhD

12:00 p.m.   To Atrium for Presentation of
                    Ray C. Fish Award and Luncheon

SESSION III

12:15 p.m.  Introduction of the Ray C. Fish Award
                   and Recipient
                   Denton A. Cooley, MD & James T. Willerson, MD

12:25 p.m.  Presentation of the Ray C. Fish Award
                   Denton A. Cooley, MD & James T. Willerson, MD

12:30 p.m.  Luncheon in honor of
                   Ray C. Fish Award Recipient

1:20 p.m.   To Auditorium for continuation of symposium

1:30 p.m.   Ray C. Fish Lecture
                  Alain Cribier, MD
                  Department of Cardiology,
                  Charles Nicolle Hospital, University of Rouen
                  Rouen, France


SESSION IV

2:00 p.m.  Advances in the Medical Treatment of CHF
                 Deborah Meyers, MD

2:30 p.m.  Advances in the Surgical Treatment of CHF
                 O.H. Frazier, MD

3:00 p.m.   Break
   
3:15 p.m.   Advances in Lung and
                  Heart-Lung Transplantation
                  Hari Mallidi, MD

3:45 p.m.   Gene Discoveries in Identifying Patients
                  at Risk for Premature MIs
                  Dianna M. Milewicz, MD, PhD

4:15 p.m.   Hypertrophic Cardiomyopathy and its Treatment
                  A.J. Marian, MD 

4:45 p.m.   Advances in Surgical Treatment of Acute and
                  Chronic CAD
                  William E. Cohn, MD

5:15 p.m.  Final Comments and Adjourn
                  James T. Willerson, MD 
  

Program Director


Dr. James T. Willerson

James T. Willerson, MD
President and Medical Director
Texas Heart Institute

Accreditation
 
Texas Heart Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation
Texas Heart Institute designates this live activity for a maximum of 7.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

An evaluation form will provide each participant the opportunity to review the speakers and their presentations, to identify educational needs, and to comment on any perceived commercial or promotional bias in the presentation.

Meeting Site and Lodging 

The symposium will be held at the Texas Heart Institute at St. Luke's Hospital -The Denton A. Cooley Building. The conference center is on the lower level (B1), green elevators.

Lodging

There are several hotels in the Texas Medical Center:

Marriott Medical Center
6580 Fannin Street
Phone: 713-796-0080  

Hilton Houston Plaza
6633 Travis Street
Phone: 713-313-4000

Hampton Inn & Suites - Medical Center/Reliant
1715 Old Spanish Trail
Phone: 713-797-0040 

Wyndham Hotel & Suites - Houston Medical Center 
6800 S. Main Street
Phone: 713-528-7744 

 

Cancellation Policy
All symposium cancellations must be received in writing by November 8, 2013. No refunds will be made after this date. A $50 processing fee will be assessed for each canceled reservation. No refund will be made for those who otherwise register, but do not attend. Texas Heart Institute reserves the right to cancel the symposium if enrollment is deemed insufficient.


Registration 
Registration fee includes the program course materials and meals.

$225 Early Registration Fee - Deadline November 1, 2013
 
$275 Late Registration Fee - After November 1, 2013
 
$150 Other Registration Fee*-  No deadline

* Fellows-in-training, residents, registered nurses, and allied health professionals. Fellows and residents must provide a statement from their program directors regarding their status.

 Register online now!

 
Find Us on Facebook!

Please contact our Webmaster with questions or comments.
Terms of Use and Privacy Policy
© Copyright Texas Heart Institute. All rights reserved.
Texas Heart Institute, Texas Heart, Texas Heart Institute Journal, THI, Heart Owner's, Leading With the Heart and Heart of Discovery are members of the
family of trademarks of the Texas Heart Institute.


U.S. NEWS America's Best Hospitals 2012-13